RecallRadar

FDA Device recall Z-0618-2019

VITEK 2 Antimicrobial Susceptibility Testing (AST) using one or more of these susceptibility products: Catalog # 410028, VITEK 2 AST-ST01 C…

On 2018-12-26 the FDA classified a Class II recall of VITEK 2 Antimicrobial Susceptibility Testing (AST) using one or more of these susceptibility products: Catalog # 410028, VITEK 2 AST-ST01 C… by Biomerieux, citing false resistant results for Streptococcus anginosus and Streptococcus constellatus strains were reported.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0618-2019
ClassificationClass II
Statusterminated
Initiated2018-10-22
Published2018-12-26
Last updated2026-09-13 11:54 UTC
CompanyBiomerieux
DistributionUS

Product

VITEK 2 Antimicrobial Susceptibility Testing (AST) using one or more of these susceptibility products: Catalog # 410028, VITEK 2 AST-ST01 Catalog # 420915, VITEK 2 AST-ST02 Catalog # 421040, VITEK 2 AST-ST03 The VITEK 2 Streptococcus Susceptibility Card is intended for use with the VITEK 2 Systems in clinical laboratories as an in vitro test to determine the susceptibility of S. pneumoniae, beta-hemolytic Streptococcus, and Viridans Streptococcus to antimicrobial agents when used as instructed.

Reason

False resistant results for Streptococcus anginosus and Streptococcus constellatus strains were reported.

Identifiers

code_infoCatalog # 410028, VITEK 2 AST-ST01 Catalog # 420915, VITEK 2 AST-ST02 Catalog # 421040, VITEK 2 AST-ST03

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0618-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.